PRIA Logo™
Take the PRIA Score
S3697119th CongressWALLET

SAVE Moms and Babies Act of 2026

Sponsored By: Senator Cindy Hyde-Smith

Introduced

Summary

Tightens federal control over abortion drugs. This bill would bar new FDA approvals and create strict limits on labeling, dispensing, practitioner certification, and safety reporting for medical abortion drugs.

Show full summary
  • Pregnant people would face a 70 day gestation cap for labeled use and must receive the drug in person from the prescribing clinician. Prescribers must give written risk information and secure the patient's acknowledgment.
  • Prescribing clinicians would need certification to assess gestational duration, diagnose ectopic pregnancies, provide surgical care for incomplete abortion or severe bleeding, and ensure access to facilities that can give blood transfusions and resuscitation. Clinicians could not dispense these drugs in the role of a pharmacist.
  • The FDA would be barred from approving new marketing applications under sections 505(b) and 505(j) for abortion drugs and from granting investigational exemptions under 505(i). Manufacturers and prescribers must report all known adverse events to the FDA and to manufacturers without including identifiable patient information.

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

1 provisions identified: 0 benefits, 1 costs, 0 mixed.

New restrictions on medication abortion access

If enacted, the bill would bar the HHS Secretary from approving new marketing applications for any "abortion drug" and would ban new investigational-use exemptions for such drugs or studies that knowingly destroy an unborn child. Any investigational exemption granted before enactment would be rescinded three years after enactment if the Secretary would then be barred from issuing it. For abortion drugs already approved on the date of enactment, the bill would impose strict safety controls (a REMS), bar use after 70 days gestation, and require in-person administration by the prescribing clinician in a clinic, medical office, or hospital (not in pharmacies). Prescribers would need certification, be able to assess gestational age and diagnose ectopic pregnancy, ensure access to surgical care and blood transfusion or resuscitation if needed, give patients written risk information and get acknowledgment, and manufacturers and clinicians would have to report serious adverse events to FDA (excluding individually identifiable patient details).

Free Policy Watch

You just read the policy. Now see what it costs you.

Pick a topic. PRIA runs your household against live legislation and sends you a free personalized readout.

Pick a topic to get started

My TaxesMy HealthMy BudgetMy MoneyMy Freedom
Or tell us something more specific

Sponsors & CoSponsors

Sponsor

Cindy Hyde-Smith

MS • R

Cosponsors

  • Steve Daines

    MT • R

    Sponsored 1/27/2026

  • Sen. Risch, James E. [R-ID]

    ID • R

    Sponsored 1/27/2026

  • Mike Rounds

    SD • R

    Sponsored 1/27/2026

  • Roger Wicker

    MS • R

    Sponsored 1/27/2026

  • Sen. Lankford, James [R-OK]

    OK • R

    Sponsored 1/27/2026

  • Sen. McConnell, Mitch [R-KY]

    KY • R

    Sponsored 1/27/2026

  • Cynthia Lummis

    WY • R

    Sponsored 1/27/2026

  • Sen. Cruz, Ted [R-TX]

    TX • R

    Sponsored 1/27/2026

  • Sen. Banks, Jim [R-IN]

    IN • R

    Sponsored 1/27/2026

  • Sen. Marshall, Roger [R-KS]

    KS • R

    Sponsored 1/27/2026

  • Katie Britt

    AL • R

    Sponsored 1/27/2026

  • Sen. Scott, Rick [R-FL]

    FL • R

    Sponsored 1/27/2026

  • Josh Hawley

    MO • R

    Sponsored 1/27/2026

  • Mike Crapo

    ID • R

    Sponsored 1/27/2026

  • Sen. Budd, Ted [R-NC]

    NC • R

    Sponsored 1/27/2026

  • Sen. Graham, Lindsey [R-SC]

    SC • R

    Sponsored 1/27/2026

  • Sen. Cassidy, Bill [R-LA]

    LA • R

    Sponsored 1/27/2026

  • Sen. Cornyn, John [R-TX]

    TX • R

    Sponsored 1/27/2026

  • Sen. Ernst, Joni [R-IA]

    IA • R

    Sponsored 1/27/2026

  • Sen. Lee, Mike [R-UT]

    UT • R

    Sponsored 1/27/2026

  • Kevin Cramer

    ND • R

    Sponsored 1/27/2026

  • Sen. Ricketts, Pete [R-NE]

    NE • R

    Sponsored 1/27/2026

  • Deb Fischer

    NE • R

    Sponsored 1/27/2026

  • Sen. Kennedy, John [R-LA]

    LA • R

    Sponsored 1/27/2026

  • John Hoeven

    ND • R

    Sponsored 1/27/2026

  • Sen. Young, Todd [R-IN]

    IN • R

    Sponsored 1/27/2026

  • Bill Hagerty

    TN • R

    Sponsored 1/27/2026

  • Sen. Cotton, Tom [R-AR]

    AR • R

    Sponsored 1/27/2026

  • Sen. Moran, Jerry [R-KS]

    KS • R

    Sponsored 1/27/2026

  • Sen. Blackburn, Marsha [R-TN]

    TN • R

    Sponsored 1/27/2026

  • Sen. Barrasso, John [R-WY]

    WY • R

    Sponsored 3/25/2026

  • Tommy Tuberville

    AL • R

    Sponsored 4/27/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation

Take It Personal

Get Your Personalized Policy View

Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in